- Home
- TXG vs ARR Comparison
TXG vs ARR Comparison
Compare TXG & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXG | ARR |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | TXG | ARR |
|---|---|---|
| Price | $24.95 | $17.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 3 |
| Target Price | $17.61 | ★ $18.00 |
| AVG Volume (30 Days) | 2.2M | ★ 2.9M |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 16.39% |
| EPS Growth | ★ 76.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $245,893,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.33 | N/A |
| P/E Ratio | ★ N/A | $27.18 |
| Revenue Growth | ★ 68.06 | N/A |
| 52 Week Low | $7.26 | $13.89 |
| 52 Week High | $24.30 | $19.31 |
Technical Indicators
Market Signals| Indicator | TXG | ARR |
|---|---|---|
| Relative Strength Index (RSI) | 70.86 | 59.84 |
| Support Level | $11.62 | $17.20 |
| Resistance Level | N/A | $18.54 |
| Average True Range (ATR) | 1.14 | 0.36 |
| MACD | 0.41 | 0.19 |
| Stochastic Oscillator | 93.57 | 99.09 |
Price Performance
Historical ComparisonAbout TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.